Palivizumab
Product Approval Information - Licensing Action
Proper name: Palivizumab
Tradename: Synagis
Manufacturer: MedImmune, Inc, Gaithersburg, MD, License #1252
Revise Package Insert: Revise Warnings and Adverse Reactions sections to include anaphylaxis and to revise the Immunogenicity subsection
Approval Date: 10/23/2002
Type of submission: Biologics license application supplement
Approval Letter
(PDF)
Label (PDF)
Last Updated: 6/11/2003
Back
to Top
Back to Index
Updated: September 25, 2003 |